Literature DB >> 16281979

Prevalence and correlates of abscesses among a cohort of injection drug users.

Elisa Lloyd-Smith1, Thomas Kerr, Robert S Hogg, Kathy Li, Julio S G Montaner, Evan Wood.   

Abstract

Recent studies have indicated that injection-related infections such as abscesses and cellulitis account for the majority of emergency room visits and acute hospitalizations accrued by local injection drug users. The objective of this analysis was to examine the prevalence and correlates of developing an abscess among a cohort of injection drug users in Vancouver and to identify socio-demographic and drug use variables associated with abscesses at baseline. We examined abscesses among participants enrolled in a prospective cohort of injection drug users. Categorical variables were analyzed using the Pearson's chi-square test and continuous variables were analyzed using the Wilcoxon signed rank test. Among 1 585 baseline participants, 341 (21.5%) reported having an abscess in the last six months. In a logistic regression model that adjusted for all variables that were associated with having an abscess at p < 0.1 in univariate analyses, female gender [odds ratio (OR) = 1.7, [95% CI: 1.2 - 2.4]; p = 0.002), recent incarceration (OR = 1.7, [95% CI: 1.3 - 2.2]; p < 0.001), sex trade involvement (OR = 1.4 [95% CI: 1.0 - 2.0]; p = 0.03), frequent cocaine use (OR = 1.5 [95% CI: 1.2 - 2.0]; p = 0.002) and HIV serostatus (OR = 1.5, [95% CI: 1.2 - 2.0]; p = 0.003) were positively associated with having an abscess. Explanations for these associations require further study, and interventions are needed to address this highly prevalent concern.

Entities:  

Year:  2005        PMID: 16281979      PMCID: PMC1308840          DOI: 10.1186/1477-7517-2-24

Source DB:  PubMed          Journal:  Harm Reduct J        ISSN: 1477-7517


Findings

The Downtown Eastside of Vancouver, Canada is a community characterized by high rates of HIV among injection drug users (IDU), and is also the setting of one of North America's highest volume needle exchange program (NEP) [1]. Recent studies have indicated that injection-related infections, such as abscesses and cellulitis, account for the majority of emergency room visits and acute hospitalizations in local IDU [2,3]. Factors associated with the development of abscesses among IDU have not been well described in settings with widespread access to sterile injecting equipment and high rates of HIV infection. In particular, abscesses are not characterized in Vancouver. However, abscesses can lead to serious complications including but not limited to osteomyelitis [4], endocarditis [5-7], and septicemia [8,9]. An ongoing prospective cohort study of IDU in Vancouver allowed for an examination of the prevalence and factors associated having an abscess in this setting. For these analyses, data was collected through the Vancouver Injection Drug Users Study (VIDUS), a prospective cohort that has been previously described in detail [1]. Data from participants who completed baseline questionnaires between May 1, 1996 and May 31, 2004 were evaluated for the present study. Participants were categorized on the basis of whether or not they reported having an abscess lasting for more than three days during the previous six months. Univariate and multivariable statistics were applied to determine factors associated with developing an abscess in the previous six months. Categorical variables were analyzed using the Pearson's chi-square test, and continuous variables were analyzed using the Wilcoxon signed rank test. Variables associated with having an abscess at p < 0.1 were considered in a subsequent logistic regression analysis. Socio-demographic and drug-using characteristics considered in these analyses as potential risk factors included: age, gender, HIV status, unstable housing, residing in Vancouver's Downtown Eastside, incarceration in the previous six months, sex trade involvement, borrowing and lending of syringes, frequent heroin and cocaine injection, binge drug use, public drug injection, requiring help with injections, and methadone maintenance therapy use. Unstable housing was defined as living in a single room occupancy hotel, transitional living arrangements, or being homeless. Individuals who reported injecting cocaine or heroin once or more a day were defined as frequent heroin and cocaine injectors. Bingeing was defined as periods in which drugs were injected more often than usual. Variable definitions were consistent with previous analyses [1]. Overall, of the 1 585 baseline VIDUS participants, 341 (21.5%) reported having an abscess in the last six months. The factors associated with having an abscess at p < 0.1 in univariate analyses included: female gender (OR = 2.4, [95%CI: 1.8 – 3.0]; p < 0.001); unstable housing (OR = 1.3, [95%CI: 1.1 – 1.8]; p = 0.01); recent incarceration (OR = 1.7, [95%CI: 1.3 – 2.1]; p < 0.001); sex trade involvement (OR = 2.4, [95%CI: 1.9 – 3.1]; p < 0.001); frequent heroin use (OR = 1.4, [95%CI: 1.1 – 1.8]; p = 0.006); frequent cocaine use (OR = 1.9, [95%CI: 1.5 – 2.5]; p < 0.001); residing in Vancouver's Downtown Eastside (OR = 1.5, [95%CI: 1.1 – 1.9]; p = 0.003); and HIV serostatus (OR = 1.8, [95%CI: 1.4 – 2.3]; p < 0.001). Table 1 shows the baseline demographic characteristics of IDU stratified by having an abscess or not in the past six months for significant variables considered in the univariate analysis.
Table 1

Baseline demographic characteristics of IDU stratified by having an abscess in the past six months.

CharacteristicNo abscess past six months n = 1 244Abscess past six months n = 341Odds Ratio (95% CI)p-value
Gender
 Male848 (68.2)162 (47.5)
 Female396 (31.8)179 (52.5)2.4 (1.9 – 3.0)< 0.001
HIV status
 Negative919 (73.9)209 (61.3)
 Positive325 (26.1)132 (38.7)1.7 (1.4 – 2.3)< 0.001
Unstable housing*
 No492 (39.5)109 (32.0)
 Yes752 (60.5)387 (68.0)1.3 (1.1 – 1.8)0.011
Recent incarceration*
 No861 (69.2)196 (57.5)
 Yes383 (30.8)145 (42.5)1.7 (1.3 – 2.1)<0.001
DTES residence*
 No552 (44.4)121 (35.5)
 Yes692 (55.6)220 (64.5)1.5 (1.1 – 1.9)0.003
Sex trade involved*
 No942 (75.7)191 (56.0)
 Yes302 (24.3)150 (44.0)2.4 (1.9 – 3.1)< 0.001
Heroin use*
 Less than daily840 (67.5)203 (59.5)
 Daily use404 (32.5)138 (40.5)1.4 (1.1 – 1.8)0.006
Cocaine use*
 Less than daily858 (69.0)182 (53.4)
 Daily use386 (31.0)159 (46.6)1.9 (1.5 – 2.5)< 0.001

Note: IDU = injection drug user, DTES = Downtown Eastside Residence. *Indicates behaviour during the six month period prior to the baseline interview.

Baseline demographic characteristics of IDU stratified by having an abscess in the past six months. Note: IDU = injection drug user, DTES = Downtown Eastside Residence. *Indicates behaviour during the six month period prior to the baseline interview. As shown in Table 2, in a logistic regression model that adjusted for all variables that were associated with having an abscess at p < 0.1 in univariate analyses, female gender [odds ratio (OR) = 1.7, [95% CI: 1.2 – 2.4]; p = 0.002), recent incarceration (OR = 1.7, [95% CI: 1.3 – 2.2]; p < 0.001), sex trade involvement (OR = 1.4 [95% CI: 1.0 – 2.0]; p = 0.030), frequent cocaine use (OR = 1.5 [95% CI: 1.2 – 2.0]; p = 0.002) and HIV serostatus (OR = 1.5, [95% CI: 1.2 – 2.0]; p = 0.003) were independently and positively associated with having an abscess.
Table 2

Logistic regression of factors associated with having an abscess

CharacteristicOdds Ratio95% C.I.p-value
Gender
 (Female vs Male)1.7(1.4 – 2.4)0.002
Frequent cocaine use
 (Yes vs No)1.5(1.2 – 2.0)0.002
Recent incarceration
 (Yes vs No)1.7(1.3 – 2.2)<0.001
Sex trade involvement
 (Yes vs No)1.5(1.1 – 2.1)0.030
HIV serostatus
 (Yes vs No)1.5(1.2 – 2.0)0.003
Logistic regression of factors associated with having an abscess Our results indicate female gender, recent incarceration, sex trade involvement, frequent cocaine use and HIV serostatus are positively associated with developing an abscess. These results are consistent with results from a study in Amsterdam where female gender and prostitution among women, as well as, frequent cocaine use were identified as independently and positively associated with skin abscesses [10]. In addition, the association between HIV-positive status and having an abscess has been noted elsewhere, and is understandable given that HIV-positive individuals may have a heightened susceptibility to bacterial infections [11,12]. Furthermore, high risk of infectious complications, such as endocarditis from abscesses [10], occur among HIV infected individuals [11]. Abscesses are a common consequence of injection drug use [13-15]. The present study demonstrates that widespread access to sterile syringes through high-volume needle exchanges and a medically supervised safer injection facility may not be sufficient to prevent high rates of abscesses among IDU in Vancouver. In addition, our findings demonstrate the need for educational and structural interventions to improve rates of sterile injecting [16,17]. Our study has limitations. First, although previous research has indicated that the VIDUS cohort is representative of Vancouver IDU [18], VIDUS is not a random sample. Second, the study relied on self-report, and therefore, the results could be susceptible to socially desirable reporting although we know of no reason why reporting abscesses would be subject to this concern. Third, the cross-sectional nature of this study precludes any conclusions regarding causal relationships between the variables studied and the outcome of interest. Further prospective study is needed to assess predictors of abscess in this setting. In summary, 21.5% of IDU participating in this study reported having an abscess in the previous six months. Results from this study indicate female gender, recent incarceration, sex trade involvement, frequent cocaine use and HIV serostatus are independently and positively associated with developing an abscess in injection drug users. Given the potential health complications arising from bacterial infections our findings highlight the need for the expansion of programs to promote safer injection practices.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

Elisa Lloyd-Smith, Thomas Kerr and Evan Wood designed the study. Kathy Li conducted the statistical analysis. Elisa Lloyd-Smith drafted the manuscript and incorporated all suggestions. All coauthors made significant contributions to the conception and design of the analyses, interpretation of the data and drafting of the manuscript, and they all approved the version to be published.
  18 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Unintended subcutaneous and intramuscular injection by drug users.

Authors:  C Hankins; D Palmer; R Singh
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

3.  Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

Authors:  Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

4.  Unexplained deaths among injection drug users: a case of probable Clostridium myonecrosis.

Authors:  N Williamson; C Archibald; J S Van Vliet
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

5.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

Review 6.  Endocarditis in injection drug users.

Authors:  D E DeWitt; D S Paauw
Journal:  Am Fam Physician       Date:  1996-05-01       Impact factor: 3.292

7.  Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection.

Authors:  T P Flanigan; J W Hogan; D Smith; E Schoenbaum; D Vlahov; P Schuman; K Mayer
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

8.  Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.

Authors:  E L Murphy; D DeVita; H Liu; E Vittinghoff; P Leung; D H Ciccarone; B R Edlin
Journal:  Clin Infect Dis       Date:  2001-06-05       Impact factor: 9.079

9.  Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; P Alcabes; D Hartel; D Buono; E E Schoenbaum; R S Klein; K Davenny; G H Friedland
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

10.  Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users.

Authors:  I J Spijkerman; E J van Ameijden; G H Mientjes; R A Coutinho; A van den Hoek
Journal:  J Clin Epidemiol       Date:  1996-10       Impact factor: 6.437

View more
  41 in total

1.  Prevalence and characteristics of femoral injection among Seattle-area injection drug users.

Authors:  Phillip O Coffin; Lara S Coffin; Shilo Murphy; Lindsay M Jenkins; Matthew R Golden
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Harmful microinjecting practices among a cohort of injection drug users in vancouver Canada.

Authors:  Beth Rachlis; Elisa Lloyd-Smith; Will Small; Diane Tobin; Dave Stone; Kathy Li; Evan Wood; Thomas Kerr
Journal:  Subst Use Misuse       Date:  2010-07       Impact factor: 2.164

Review 3.  Evidence-based approach to abscess management.

Authors:  Christina Korownyk; G Michael Allan
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

4.  US hospitalizations and costs for illicit drug users with soft tissue infections.

Authors:  Traci A Takahashi; Matthew L Maciejewski; Katharine Bradley
Journal:  J Behav Health Serv Res       Date:  2009-04-21       Impact factor: 1.505

5.  Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Authors:  Hudson Reddon; Evan Wood; Mark Tyndall; Calvin Lai; Robert Hogg; Julio Montaner; Thomas Kerr
Journal:  AIDS Educ Prev       Date:  2011-10

6.  Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities.

Authors:  David S Fink; Suzanne P Lindsay; Donald J Slymen; Alex H Kral; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2013-04-12       Impact factor: 2.164

7.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

8.  Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming.

Authors:  Elisa Lloyd-Smith; Beth S Rachlis; Diane Tobin; Dave Stone; Kathy Li; Will Small; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2010-03-19

9.  Skin and soft tissue infections and vascular disease among drug users, England.

Authors:  Charles Irish; Roy Maxwell; Mark Dancox; Paul Brown; Caroline Trotter; Julia Verne; Mary Shaw
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

10.  Harm reduction in hospitals: is it time?

Authors:  Beth S Rachlis; Thomas Kerr; Julio S G Montaner; Evan Wood
Journal:  Harm Reduct J       Date:  2009-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.